What is he best known for?
The fields of study he is best known for:
- Enzyme
- Amino acid
- Antibody
Cell adhesion molecule, Cell adhesion, Cell biology, Biochemistry and Integrin are his primary areas of study.
His Cell adhesion molecule research integrates issues from Colitis, Inflammation, Molecular biology, E-selectin and Cell–cell interaction.
His work focuses on many connections between Molecular biology and other disciplines, such as VCAM-1, that overlap with his field of interest in Intercellular Adhesion Molecule-1.
His biological study spans a wide range of topics, including Endothelial stem cell and Tumor necrosis factor alpha.
His study explores the link between Biochemistry and topics such as Angiogenin that cross with problems in Proline, Isoelectric point and Sequence.
Roy R. Lobb combines subjects such as Chemokine and Fibronectin with his study of Integrin.
His most cited work include:
- VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/Fibronectin binding site (1664 citations)
- Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. (1554 citations)
- Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells (793 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Integrin, Cell adhesion molecule, Molecular biology, Immunology and Cell adhesion.
The study incorporates disciplines such as Alpha, Fibronectin, Integrin alpha M, Cell biology and Monoclonal antibody in addition to Integrin.
VCAM-1 is the focus of his Cell adhesion molecule research.
His study focuses on the intersection of Molecular biology and fields such as VLA-4 with connections in the field of CD49d.
He has included themes like Inflammatory bowel disease and Pharmacology in his Immunology study.
As part of the same scientific family, Roy R. Lobb usually focuses on Cell adhesion, concentrating on Tumor necrosis factor alpha and intersecting with Eosinophil.
He most often published in these fields:
- Integrin (32.19%)
- Cell adhesion molecule (28.08%)
- Molecular biology (28.77%)
What were the highlights of his more recent work (between 2005-2021)?
- Cancer research (8.22%)
- Antigen (9.59%)
- CD19 (6.16%)
In recent papers he was focusing on the following fields of study:
Roy R. Lobb mostly deals with Cancer research, Antigen, CD19, Fusion protein and Cell biology.
He interconnects Cancer, Receptor tyrosine kinase, Immune system and S cell in the investigation of issues within Cancer research.
His work carried out in the field of Antigen brings together such families of science as T cell, Viral vector, Cell therapy, Cancer therapy and Antibody.
In his work, Cytotoxic T cell is strongly intertwined with B cell, which is a subfield of CD19.
His work in Fusion protein covers topics such as Yeast display which are related to areas like Epitope mapping, Computational biology and Conformational epitope.
The various areas that Roy R. Lobb examines in his Cell biology study include Cancer cell and Cancer stem cell.
Between 2005 and 2021, his most popular works were:
- αvβ6 Integrin Regulates Renal Fibrosis and Inflammation in Alport Mouse (155 citations)
- Combinatorial targeting and discovery of ligand-receptors in organelles of mammalian cells. (42 citations)
- Targeting the interleukin‐11 receptor α in metastatic prostate cancer: A first‐in‐man study (35 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Amino acid
- Antibody
The scientist’s investigation covers issues in Cancer research, Receptor, Nephropathy, Glomerulonephritis and Internal medicine.
Roy R. Lobb combines subjects such as Cancer, Receptor tyrosine kinase, DNA damage and S cell with his study of Cancer research.
His research integrates issues of Intracellular, Organelle, Cell biology and Phage display, Peptide in his study of Receptor.
Other disciplines of study, such as Cytokine, Kidney disease, Glomerular Filtration Barrier, Creatinine and Proteinuria, are mixed together with his Nephropathy studies.
His Glomerulonephritis research includes elements of Nephritis, Pathology and Renal fibrosis.
His study brings together the fields of Oncology and Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
